Inventor · Novato, CA, US

Daniel J. Wendt

23Patents
7h-index
29Co-inventors
69Inventor score

Filing activity: Oct 7, 1992 → Jan 20, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5324649A Enzyme-containing granules coated with hydrolyzed polyvinyl alcohol or copolymer thereof Chemistry; Metallurgy 93 Expired
US7534595B2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof Human Necessities 56 Active
US7537923B2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof Human Necessities 35 Active
US8198242B2 Variants of C-type natriuretic peptide Physics 29 Active
US7790433B2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof Human Necessities 24 Active
US8377884B2 Variants of C-type natriuretic peptides Human Necessities 17 Active
US8598121B2 Variants of C-type natriuretic peptide Physics 7 Active
US9834588B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Chemistry; Metallurgy 6 Active
US9834587B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Chemistry; Metallurgy 6 Active
US9376480B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Chemistry; Metallurgy 5 Active
US10646550B2 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Human Necessities 4 Active
US9845346B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Chemistry; Metallurgy 4 Active
US9771408B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Human Necessities 4 Active
US10301369B2 Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins Chemistry; Metallurgy 4 Active
US11254725B2 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Chemistry; Metallurgy 2 Active
US10221408B2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof Chemistry; Metallurgy 2 Active
USRE48267E1 Variants of C-type natriuretic peptide General 1 Active
US11505790B2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof Chemistry; Metallurgy 1 Active
US9907834B2 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Human Necessities 1 Active
US12076372B2 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Human Necessities 0 Active
USRE46707E1 Variants of C-type natriuretic peptide General 0 Active
US11590204B2 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Human Necessities 0 Active
US11911446B2 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.